Genome-wide exploration of the drug action of capreomycin on Mycobacterium tuberculosis using Affymetrix oligonucleotide GeneChips
Authors:
- Li M. FuLFLi M. Fu
- Thomas M. ShinnickTSThomas M. Shinnick
- 1 March 2007
- journal article
- Published by Elsevier in Journal of Infection
- Vol. 54 (3) , 277-284
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Update on the Treatment of Tuberculosis and Latent Tuberculosis InfectionJAMA, 2005
- Capreomycin is active against non-replicating M. tuberculosisAnnals of Clinical Microbiology and Antimicrobials, 2005
- Mutation of tlyA Confers Capreomycin Resistance in Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2005
- The use of microarray analysis to determine the gene expression profiles of Mycobacterium tuberculosis in response to anti-bacterial compoundsTuberculosis, 2004
- Global Drug-Resistance Patterns and the Management of Latent Tuberculosis Infection in Immigrants to the United StatesNew England Journal of Medicine, 2002
- Differential Gene Expression Patterns Revealed by Oligonucleotide Versus Long cDNA ArraysToxicological Sciences, 2002
- Multidrug-resistant tuberculosisInfectious Disease Clinics of North America, 2002
- Adult tuberculosis overview: African versus Western perspectivesCurrent Opinion in Pulmonary Medicine, 2000
- Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridizationProceedings of the National Academy of Sciences, 1999
- In Vitro Activities of Fourteen Antimicrobial Agents Against Drug Susceptible and Resistant Clinical Isolates of Mycobacterium tuberculosis and Comparative Intracellular Activities Against the Virulent H37Rv Strain in Human MacrophagesCurrent Microbiology, 1996